4Swerdlow SH, Campo E, Harris NL. WHO classification of humours of haematopoietic and lymphoid tissues 4th Edition. Lyon: Interna- tional Agency for Research on Cancer (IARC)69008,2008:10-367.
5Bennett JM, Catavosky D, Daniel MT, et al. Proposals for the classi- fication of acute leukaemias French-American-British (FAB) Co- operative group. Br J Haematol,1976 ,33 :451.
6Warren S,C_,ates O. Multiple primary malignant tumors:a survey of the literature and a statistical study. Am J Caneer,1932 ,16 :1358-1414.
7Sabine K, Konstanze D, Jttrgen K. The impact of therapy-related a-cute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood,2011, 117 : 2137-2145.
8Hijiya N ,Ness KK,Ribeiro RC. Acute leukemia as a secondary ma- lignancy in children and adolescents current findings and issues. Cancer,2009,115( 1 )23-25.
9Larson RA. Etiology and management of therapy-related myeloid leu- kemia. Hematol Am Soe Hematol Edue Program,2007,1:453-459.
